TY - JOUR
T1 - Delayed vs early cardioversion in patients with paroxysmal atrial fibrillation
T2 - a population-based study (2015-2020)
AU - Mohamed, Mohamed Salah
AU - Hashem, Anas
AU - Khalouf, Amani
AU - Osama, Muhammad
AU - Pendela, Venkata Satish
AU - Rai, Devesh
AU - Aronow, Wilbert S.
AU - Balmer-Swain, Mallory
N1 - Publisher Copyright:
© 2023 Future Medicine Ltd.
PY - 2023/7/1
Y1 - 2023/7/1
N2 - Aim: There is limited data on clinical outcomes of delayed cardioversion (DCV) compared with early cardioversion (ECV) in paroxysmal atrial fibrillation (AF) patients. Methods: We utilized data from National Inpatient Sample (2015-2020) and propensity-score matched analysis to determine adjusted odds ratio (aOR) of major clinical outcomes, including 17,879 AF cases: 9725 and 8154 underwent ECV and DCV, respectively. Results: Compared with ECV, DCV was associated with higher odds of acute heart failure (AHF; aOR 1.79 [1.67-1.92]; p < 0.01), median length of stay (4 vs 2 days; p < 0.01) and cost of hospitalization ($33,410 vs $21,738; p < 0.01) with no significant difference in inpatient mortality and other cardiovascular and neurological outcomes. Conclusion: Compared with ECV, DCV was associated with more AHF and resource utilization.
AB - Aim: There is limited data on clinical outcomes of delayed cardioversion (DCV) compared with early cardioversion (ECV) in paroxysmal atrial fibrillation (AF) patients. Methods: We utilized data from National Inpatient Sample (2015-2020) and propensity-score matched analysis to determine adjusted odds ratio (aOR) of major clinical outcomes, including 17,879 AF cases: 9725 and 8154 underwent ECV and DCV, respectively. Results: Compared with ECV, DCV was associated with higher odds of acute heart failure (AHF; aOR 1.79 [1.67-1.92]; p < 0.01), median length of stay (4 vs 2 days; p < 0.01) and cost of hospitalization ($33,410 vs $21,738; p < 0.01) with no significant difference in inpatient mortality and other cardiovascular and neurological outcomes. Conclusion: Compared with ECV, DCV was associated with more AHF and resource utilization.
KW - atrial fibrillation
KW - cerebrovascular disease
KW - electrophysiology
KW - heart failure
KW - stroke
UR - https://www.scopus.com/pages/publications/85174752247
U2 - 10.2217/fca-2023-0069
DO - 10.2217/fca-2023-0069
M3 - Article
C2 - 37650496
AN - SCOPUS:85174752247
SN - 1479-6678
VL - 19
SP - 441
EP - 452
JO - Future Cardiology
JF - Future Cardiology
IS - 9
ER -